Endocrine Society And American Academy Of Pediatrics Respond To Cass, Reject Bans
Endocrine Society And American Academy Of Pediatrics Respond To Cass, Reject Bans
In recent weeks, the Cass Review out of the United Kingdom has been used to argue for bans on care. The Endocrine Society and American Academy of Pediatrics respond, rejecting such arguments.
Over the past few weeks, Dr. Hillary Cass has begun giving interviews in the United States to defend her report targeting transgender care. The Cass Review has faced criticism for its alleged anti-trans political ties, biased findings, promotion of conversion therapists, and poor treatment of evidence regarding transgender care. In an interview with NPR, Dr. Cass claimed that transgender individuals' care should be judged by their "employment," rather than their satisfaction with the care received. Later, during an interview with The New York Times, Cass misleadingly stated that she had not been contacted by any lawmakers or U.S. health bodies, despite having met with political appointees of Gov. Ron DeSantis to discuss banning trans care before her report was published. In response, both the American Academy of Pediatrics and the Endocrine Society have categorically rejected the review as a justification for bans on care and have challenged many of its alleged findings.
In a statement released by the Endocrine Society, they reiterated that they stand by their guidelines around the provision of gender affirming care for transgender youth: “We stand firm in our support of gender-affirming care. Transgender and gender-diverse people deserve access to needed and often life-saving medical care. NHS England’s recent report, the Cass Review, does not contain any new research that would contradict the recommendations made in our Clinical Practice Guideline on gender-affirming care… Medical evidence, not politics, should inform treatment decisions.”
The Endocrine Society defended its guidelines, highlighting that they cite over 260 research studies to support their recommendations on transgender care. Moreover, the guidelines were developed with input from more than 18,000 members who had the opportunity to comment. This process is notably more transparent than the Cass Review, whose advisory members have been kept secret. Investigations have revealed that several members are part of an anti-trans lobbying organization, SEGM, which the Southern Poverty Law Center has described as "the hub" of an "anti-LGBTQ pseudoscience network."
“Although the scientific landscape has not changed significantly, misinformation about gender-affirming care is being politicized. In the United States, 24 states have enacted laws or policies barring adolescents’ access to gender-affirming care, according to the Kaiser Family Foundation. In seven states, the policies also include provisions that would prevent at least some adults over age 18 from accessing gender-affirming care,” the Endocrine Society Letter reads, “Transgender and gender-diverse teenagers, their parents, and physicians should be able to determine the appropriate course of treatment. Banning evidence-based medical care based on misinformation takes away the ability of parents and patients to make informed decisions..”
You can see the Endocrine Society’s release here:
Similar sentiments were shared by Dr. Ben Hoffman, president of the American Academy of Pediatrics, who responded to the Cass Review, “What we’re seeing more and more is that the politically infused public discourse is getting this wrong and it’s impacting the way that doctors care for their patients. Physicians must be able to practice medicine that is informed by their medical education, training, experience, and the available evidence, freely and without the threat of punishment. Instead, state legislatures have passed bills to ban and restrict gender-affirming care, which means that right now, for far too many families, their zip code determines their ability to seek the health care they need. Politicians have inserted themselves into the exam room, and this is dangerous for both physicians and for families.”
Transgender care saves lives. A Cornell review of more than 51 studies determined that trans care significantly improves the mental health of transgender people. One major study even noted a 73% lower suicidality among trans youth who began care. In a recent article published in the Journal of Adolescent Health in April of 2024, puberty blockers were found to significantly reduce depression and anxiety. In Germany, a recent review by over 27 medical organizations has judged that “not providing treatment can do harm” to transgender youth. The evidence around transgender care led to a historic policy resolution condemning bans on gender affirming care by the American Psychological Association, the largest psychological association in the world, which was voted on by representatives of its 157,000 members.
Interestingly, Cass herself advocated against care bans in her most recent New York Times interview released today, where she stated, “There are young people who absolutely benefit from a medical pathway, and we need to make sure that those young people have access,” although she added a caveat that those young people should be forced to consent to research in order to access care, leaving many to question the ethics of such an approach.
Regardless of Cass’s statements, her review is being used to justify bans in the United States and worldwide. In the United Kingdom, her report has led to bans on puberty blockers in England and even inquiries into adult care. In the United States, Senators in South Carolina used it to pass a total care ban for trans youth in the state. Now, major medical organizations have responded firmly against the idea that evidence around gender affirming care is weak, challenging states who use such misleading claims to ban transgender care as practicing politics, not medicine.
You can find the statements from the American Academy of Pediatrics and the Endocrine Society here:
There is an abundance of high-quality evidence that Dr. Hillary Cass is a transphobic shill.
So glad they put out these statements, hopefully it can help stem some of the harm Cass has done.